From: Molecular mechanisms involved in regulating protein activity and biological function of MST3
Biological function | Regulatory mechanism | References |
---|---|---|
Apoptosis | Â | Â |
 Induce apoptosis | Activate caspase 3 in human trophoblast cells | [30] |
Suppress JNK in human colon carcinoma cells | [6] | |
Upregulate cytoprotective HO-1 in colon carcinoma cells | [6] | |
Disrupt mitochondrial membrane potential in human cervix HeLa cells | [3] | |
Immune regulation | Â | Â |
 Inhibit neutrophil-mediated inflammatory response | Inhibit neutrophil degranulation | [37] |
 Promote anti-tumoral immune response | Associate with decreased ratio of MDSCs and TAMs in gastric tumor tissue | |
 | Associate with increased percentage of CD4+ T cells in gastric tumor tissue | |
Metabolism | Â | Â |
 Increase insulin resistance and blood glucose levels | Deactivate IRS1-FOXO1 pathway | [40] |
 Promote lipid accumulation | Increase the expression of lipogenic genes and ACC | [41] |
Inhibit β-oxidation and triacylglycerol secretion | [42] | |
Increase fatty acid influx and lipid synthesis | [42] | |
Hypertension | Â | Â |
 Maintain Na+/K+ homeostasis and blood pressure stability | Inhibit Na+ channel and Na+-K+-Cl− cotransporter activities | |
Suppress WNK4 expression | [43] | |
Tumor progression | Â | Â |
 Promote breast cancer growth | Activate VAV2-Rac1-cyclin D1 pathway | [4] |
 Promote gastric cancer growth | Enhance p21 expression | [7] |
 Inhibit migration of adenocarcinoma | Inhibit paxillin phosphorylation via PTP-PEST | [28] |
Suppress migration of gastric cancer | Increase expression of CDH1 (E-Cadherin) and CD44 | [38] |
CNS development | Â | Â |
 Promote radial neuronal migration and final neuronal positioning | Suppress Rho-GTPase activity of RhoA | [31] |
 Promote the development of filopodia, dendritic spine and excitatory synapse | Phosphorylate TAO1/2 kinases | [44] |
 Promote neuronal regeneration | Activate P42/44MAPK and LIMK/Cofilin pathway | [45] |